Clinical Trial Update: Treatment of Multiple Sclerosis With Copaxone and Albuterol [NA]

View source ↗

Summary

This is an update on a completed clinical trial evaluating Copaxone (glatiramer acetate) in combination with albuterol for multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Albuterol (albuterol)
• COPAXONE (GLATIRAMER ACETATE)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Autoimmune Diseases, Multiple Sclerosis | NA | Status: COMPLETED